US kefir maker Lifeway Foods turned down two offers from the French giant – one of its shareholders – last year.

Levy reported R&D expenses of $38.3 million for Q2 2025, down from $39.3 million in the prior year period, attributed to the conclusion of the lorundrostat pivotal program, partially offset by ...

Candidates are nominated by political parties or alliances, and the election is conducted by members of both houses of ...

The FDA accepted vepdegestrant’s new drug application for ER+/HER2–, ESR1-mutated advanced breast cancer with a June 5, 2026, ...

BJP national president JP Nadda said it is important to regularly hold meetings of the parliamentary standing committees so ...

The ruling National Democratic Alliance (NDA), at its meeting held on Thursday, unanimously authorised Prime Minister ...

Discover key insights from Xenon Pharmaceuticals' Q2 2025 earnings call, including milestones in epilepsy, depression trials, and a strong cash ...

The FDA accepts a new drug application for vepdegestrant, a promising oral PROTAC developed by Arvinas and Pfizer, signaling ...

National Democratic Alliance on Thursday authorised PM Modi and BJP president J P Nadda to finalise the alliance's ...

Panneerselvam has quit the NDA, causing significant ripples in Tamil Nadu's political landscape. Despite his departure, the ...

The National Democratic Alliance (NDA) is likely to announce its vice presidential candidate today after former Vice President Jagdeep Dhankhar resigned earlier in July. Bangladesh’s Chief Advisor Muh ...

Q2 2025 Management View CEO Yu-Hsin Lin reported "excellent progress in the quarter towards advancing Tinlarebant narrowband in patients living with Stargardt's disease and geographic atrophy," ...